Xenon Pharmaceuticals grants 24,250 stock options and 14,250 RSUs to nine new employees
XENE•Xenon Pharmaceuticals granted 24,250 share options and 14,250 restricted share units to nine new non-officer employees, effective October 29, 2026.
1. Employee equity grants
Each option has a 10-year term. Options vest 25% on an employee’s first start-date anniversary, with one thirty-sixth of the remainder vesting monthly thereafter; restricted share units vest 25% on each of the first four grant-date anniversaries. Vesting is subject to continued service with the company.
